Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19891| Title: | Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | *Adenocarcinoma/drug therapy/mortality/secondary,Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/administration & dosage/adverse,effects/*therapeutic use,Camptothecin/administration & dosage/adverse effects/analogs &,derivatives/therapeutic use,Disease-Free Survival,Drug Administration Schedule,Female,Humans,Male,Middle Aged,Neoplasms, Unknown Primary/*drug therapy/mortality,Organoplatinum Compounds/administration & dosage/adverse effects/therapeutic use |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19891 |
| ISSN: | 0344-5704 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/17901952 http://www.springerlink.com/content/n82v1wj2u2l46925/fulltext.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Briasoulis-2008-Multicenter phase-II.pdf | 329.17 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
